These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 22997212
1. Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission. Hudgens MG, Taha TE, Omer SB, Jamieson DJ, Lee H, Mofenson LM, Chasela C, Kourtis AP, Kumwenda N, Ruff A, Bedri A, Jackson JB, Musoke P, Bollinger RC, Gupte N, Thigpen MC, Taylor A, van der Horst C. Clin Infect Dis; 2013 Jan; 56(1):131-9. PubMed ID: 22997212 [Abstract] [Full Text] [Related]
2. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, Li Q, Mipando L, Nkanaunena K, Mebrahtu T, Bulterys M, Fowler MG, Taha TE. N Engl J Med; 2008 Jul 10; 359(2):119-29. PubMed ID: 18525035 [Abstract] [Full Text] [Related]
3. Antiretroviral interventions for preventing breast milk transmission of HIV. White AB, Mirjahangir JF, Horvath H, Anglemyer A, Read JS. Cochrane Database Syst Rev; 2014 Oct 04; 2014(10):CD011323. PubMed ID: 25280769 [Abstract] [Full Text] [Related]
4. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Kesho Bora Study Group, de Vincenzi I. Lancet Infect Dis; 2011 Mar 04; 11(3):171-80. PubMed ID: 21237718 [Abstract] [Full Text] [Related]
5. Interventions for preventing late postnatal mother-to-child transmission of HIV. Horvath T, Madi BC, Iuppa IM, Kennedy GE, Rutherford G, Read JS. Cochrane Database Syst Rev; 2009 Jan 21; 2009(1):CD006734. PubMed ID: 19160297 [Abstract] [Full Text] [Related]
6. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. Chasela CS, Hudgens MG, Jamieson DJ, Kayira D, Hosseinipour MC, Kourtis AP, Martinson F, Tegha G, Knight RJ, Ahmed YI, Kamwendo DD, Hoffman IF, Ellington SR, Kacheche Z, Soko A, Wiener JB, Fiscus SA, Kazembe P, Mofolo IA, Chigwenembe M, Sichali DS, van der Horst CM, BAN Study Group. N Engl J Med; 2010 Jun 17; 362(24):2271-81. PubMed ID: 20554982 [Abstract] [Full Text] [Related]
7. Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial. Jamieson DJ, Chasela CS, Hudgens MG, King CC, Kourtis AP, Kayira D, Hosseinipour MC, Kamwendo DD, Ellington SR, Wiener JB, Fiscus SA, Tegha G, Mofolo IA, Sichali DS, Adair LS, Knight RJ, Martinson F, Kacheche Z, Soko A, Hoffman I, van der Horst C, BAN study team. Lancet; 2012 Jun 30; 379(9835):2449-2458. PubMed ID: 22541418 [Abstract] [Full Text] [Related]
8. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L. J Infect Dis; 2009 Nov 15; 200(10):1490-7. PubMed ID: 19832114 [Abstract] [Full Text] [Related]
9. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Cochrane Database Syst Rev; 2011 Jul 06; (7):CD003510. PubMed ID: 21735394 [Abstract] [Full Text] [Related]
10. Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine. Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, John-Stewart GC. AIDS; 2005 Sep 02; 19(13):1415-22. PubMed ID: 16103773 [Abstract] [Full Text] [Related]
11. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P. Cochrane Database Syst Rev; 2007 Jan 24; (1):CD003510. PubMed ID: 17253490 [Abstract] [Full Text] [Related]
12. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB. Lancet; 1999 Sep 04; 354(9181):795-802. PubMed ID: 10485720 [Abstract] [Full Text] [Related]
13. A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers. Gray GE, Urban M, Chersich MF, Bolton C, van Niekerk R, Violari A, Stevens W, McIntyre JA, PEP Study Group. AIDS; 2005 Aug 12; 19(12):1289-97. PubMed ID: 16052084 [Abstract] [Full Text] [Related]
14. Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial. Fowler MG, Coovadia H, Herron CM, Maldonado Y, Chipato T, Moodley D, Musoke P, Aizire J, Manji K, Stranix-Chibanda L, Fawzi W, Chetty V, Msweli L, Kisenge R, Brown E, Mwatha A, Eshleman SH, Richardson P, Allen M, George K, Andrew P, Zwerski S, Mofenson LM, Jackson JB, HPTN 046 Protocol Team. J Acquir Immune Defic Syndr; 2014 Mar 01; 65(3):366-74. PubMed ID: 24189151 [Abstract] [Full Text] [Related]
15. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S, Kanshana S, McIntosh K, Thaineua V, Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med; 2004 Jul 15; 351(3):217-28. PubMed ID: 15247338 [Abstract] [Full Text] [Related]
16. Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis. Permar SR, Salazar MG, Gao F, Cai F, Learn GH, Kalilani L, Hahn BH, Shaw GM, Salazar-Gonzalez JF. Retrovirology; 2013 Aug 14; 10():88. PubMed ID: 23941304 [Abstract] [Full Text] [Related]
17. Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count. Omer SB, Six Week Extended Dose Nevirapine (SWEN) Study Team. AIDS; 2011 Mar 27; 25(6):767-76. PubMed ID: 21330912 [Abstract] [Full Text] [Related]
18. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial. Coovadia HM, Brown ER, Fowler MG, Chipato T, Moodley D, Manji K, Musoke P, Stranix-Chibanda L, Chetty V, Fawzi W, Nakabiito C, Msweli L, Kisenge R, Guay L, Mwatha A, Lynn DJ, Eshleman SH, Richardson P, George K, Andrew P, Mofenson LM, Zwerski S, Maldonado Y, HPTN 046 protocol team. Lancet; 2012 Jan 21; 379(9812):221-8. PubMed ID: 22196945 [Abstract] [Full Text] [Related]
19. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection. Suksomboon N, Poolsup N, Ket-Aim S. J Clin Pharm Ther; 2007 Jun 21; 32(3):293-311. PubMed ID: 17489882 [Abstract] [Full Text] [Related]
20. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, Gilbert PB, Stevens L, Peter T, Kim S, van Widenfelt E, Moffat C, Ndase P, Arimi P, Kebaabetswe P, Mazonde P, Makhema J, McIntosh K, Novitsky V, Lee TH, Marlink R, Lagakos S, Essex M, Mashi Study Team. JAMA; 2006 Aug 16; 296(7):794-805. PubMed ID: 16905785 [Abstract] [Full Text] [Related] Page: [Next] [New Search]